Ask AI
ProCE Banner Series

Setting New Standards With TROP2-Directed Therapy in NSCLC: Leveraging ADC Innovation to Meet Unmet Patient Needs

This activity explores emerging clinical evidence and practical considerations for integrating TROP2 ADCs in NSCLC into personalized treatment strategies. Learners will gain a concise, data-driven overview of how these novel therapies may address unmet needs in advanced lung cancer care.

  AAPA
  | ACPE
  | AMA
  | ANCC
Who Should Attend

This activity has been designed to meet the educational needs of oncologists, nurse practitioners, physician associates, oncology nurses, pharmacists, and other healthcare professionals involved in the management of patients with NSCLC.

All Events

Setting New Standards With TROP2-Directed Therapy in NSCLC: Leveraging ADC Innovation to Meet Unmet Patient Needs

Upcoming Events

January

29

2026

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve learners’ knowledge, confidence, and competence in treating patients with NSCLC.

Target Audience
This activity has been designed to meet the educational needs of oncologists, nurse practitioners, physician associates, oncology nurses, pharmacists, and other healthcare professionals involved in the management of patients with NSCLC.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Explain the significance of TROP2 expression in NSCLC and the therapeutic rationale for targeting TROP2 with antibody–drug conjugates

  • Compare and contrast potential indications, efficacy, and toxicity profiles among available and investigational agents targeting TROP2 in NSCLC

  • Analyze and integrate TROP2 ADCs for patients with NSCLC based on a comprehensive understanding of available clinical data and expert recommendations

  • Design a tailored supportive care plan to manage treatment-related AEs in patients receiving TROP2–targeted therapy, emphasizing QoL and patient comfort

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-26-041-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim commensurate with the extent of their participation.

IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191